|
Match
|
Document |
Document Title |
|
|
7622576 |
Halide-free glucosamine base and method of preparation
A glucosamine base having a pure level of at least about 99.0 wt. % and a maximum halide content of 0.01 wt. %. The pure glucosamine base is prepared by reacting a glucosamine halide, e.g.,...
|
|
|
7612049 |
Method of inhibition the growth of algae
The inhibition of Chlorophyta growth in water needed to be treated can be accomplished by the addition of about 100 ppm glucosamine. The inhibition of Microcystic aeruginosa and Microcystis...
|
|
|
7605146 |
Process for producing an amide compound
There is disclosed a process for producing an amide compound, which process is characterized in that a compound having an amino group are reacted with a polyaminopolycarboxylic acid anhydride in...
|
|
|
7592327 |
Asthma/allergy therapy that targets T-lymphocytes and/or eosinophils
A pharmaceutical composition for the treatment and/or prophylaxis of diseases caused by type I hypersensitivity reactions consisting essentially of Glicophosphopeptical, or pure Nigella Sativa ...
|
|
|
7553820 |
Mevalonic acid derivatives
This invention provides compounds having excellent antitumor activity, which are represented by the following formulae
in which R 1 , R 2 , R 3 , m, n and R 4 have the significations as...
|
|
|
7544671 |
Stabilized hyaluronan preparations and related methods
Stabilized hyaluronan preparations wherein hyaluronan is combined with a polyglycol, such as polyethylene glycol. Stabilized hyaluronan preparations of this invention may maintain their viscosity...
|
|
|
7504387 |
Glycosaminoglycan composition and method for treatment and prevention of interstitial cystitis
The invention provides compositions and methods useful for the treatment and/or prevention of interstitial cystitis and/or a related urinary tract condition in man or in animals. Specifically,...
|
|
|
7498317 |
Antibacterial agents and process for producing the same
An antibacterial agent showing a high affinity for Helicobactor pyroli and having an antibacterial effect specific to H. Pyroli. The agent has a chemical structure wherein an antibacterial...
|
|
|
7494674 |
Nutraceutical with tart cherries and method of treatment therewith
The present disclosure provides a nutraceutical for the use of a vacuolar flavonoid pigment from a natural source such as tart cherries as an additional compound as part of a mixture including at...
|
|
|
7485718 |
Chemical synthesis of low molecular weight polyglucosamines and polygalactosamines
A process for the synthesis of beta linked low molecular weight polymers of galactosamine and glucosamine has been developed. Through the use of high amounts of activating agents, efficient...
|
|
|
7485629 |
Composition and method for treatment of joint damage
The invention provides compositions useful for the treatment and/or prevention of damage to diarthrodial (synovial) joints and, in particular, traumatic synovitis, inflammation of the synovial...
|
|
|
7482026 |
Compositions and methods directed towards sore muscles and joints
Chemical formulations and methods for reducing muscle and joint soreness are disclosed. A representative chemical formulation includes compounds such as a selenium-compound, chondroitin sulfate,...
|
|
|
7468195 |
Skin treatment preparation
A skin treatment preparation including carriers, a medicinal vector encapsulating a plant extract (Cucumis melo protein extract) rich in reductase, catalase and superoxide dismutase is...
|
|
|
7435812 |
Method for preparing a glucosamine compound and compound thus obtained
Method for preparing a compound comprising protonated glucosamine and Cl − , Na + and SO 4 2− ions, in which (a) glucosamine hydrochloride and a stoichiometric excess of sodium sulphate are...
|
|
|
7429573 |
Method for increasing the bone mineral density and bone micro-architecture or connectivity of a mammal using N-acylated glucosamines
A method of treating a mammal for a purpose selected from the group consisting of (a) increasing bone mineral density (BMD), (b) treating low BMD, (c) preventing and treatment of low impact...
|
|
|
7425573 |
Use of annellated pyrrole compounds in the treatment of articular cartilage or subchondral bone degeneration
Treating or preventing degeneration or destruction of articular cartilage and/or subchondral bone in the affected joint of a mammal is accomplished by administering a compound of formula (I),...
|
|
|
7416748 |
Arthritis phyto-nutraceutical synergistic composition
A Phytoceutical composition for the prevention and treatment of arthritis is provided. A specific combination of extracts of plants and nutraceuticals is taught, as well as principles for varying...
|
|
|
7393937 |
N-acetylglucosamine derivatives and use thereof
The present invention relates to An N-acetylglucosamine derivative represented by the following formula (1), and a hyaluronic acid production promoting agent containing the same and a skin external...
|
|
|
7388001 |
Halide-free glucosamine sulfate compositions and methods of preparation
Glucosamine sulfate having a purity of at least about 99 wt. %, and a maximum halide content of about 0.01 wt. %. Preferably, the glucosamine sulfate is stabilized by coating it with at least one...
|
|
|
7388000 |
Halide-free glucosamine phosphate compositions and methods of preparation
Glucosamine phosphate having a purity of at least about 99 wt. %, and a maximum halide content of about 0.01 wt. %. Preferably, the glucosamine phosphate is stabilized by coating it with at least...
|
|
|
H002218 |
Glucosamine and method of making glucosamine from microbial biomass
Glucosamine suitable for human or animal consumption is disclosed. The glucosamine is derived from microbial biomass containing chitin. Suitable starting materials include substantially uniform...
|
|
|
7345031 |
Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation and use
Hydrophilic transportable N-linked glycosyl dopaminergic prodrug compounds according to FORMULA V and methods of their use,
wherein,
Ring 1 comprises an aryl or heteroaryl ring having 4...
|
|
|
7345030 |
Use of n-acetyl-d-aminoglycosamine in treatment of organ lesions related to toxicosis of drugs or chemicals
The present invention is directed to the use of N-acetyl-D-glucosamine to treat organ lesions caused by toxicants and drugs. The present invention is also directed to a method for treating organ...
|
|
|
7338943 |
Hyaluronic acid in soft gel form
An orally administered soft gelatin formulation preparation of low molecular weight Hyaluronic Acid (HA) for use as a nutritional supplement to provide the primary benefit of internally causing the...
|
|
|
7338942 |
Composition and method for maintaining healthy mobile joints and cartilage
Compositions and methods for maintaining healthy mobile joints and cartilage in humans and animals are disclosed. The composition comprises glucosamine and chondroitin dispersed in a...
|
|
|
7335384 |
Nutrient compositions for the treatment and prevention of inflammation and disorders associated therewith
The present disclosure describes a novel composition for the treatment and/or prevention of neurogenic inflammation. Such composition is also useful in the treatment and/or prevention of disease...
|
|
|
7323452 |
Method for the accelerated in vivo removal of ethanol
A method for accelerating the process of removing ethanol from the blood through the use of certain additives that accelerate the metabolic oxidation of ethanol, and others which in addition act as...
|
|
|
7316989 |
Compositions inducing plants disease-resistance and process for producing the same
There is provided a plant disease resistance-inducing composition comprising a filamentous fungus-derived glycosphingolipid. There is also provided a method for controlling a plant disease,...
|
|
|
7259152 |
Methods and compositions using sulodexide for the treatment of diabetic nephropathy
The present invention provides oral formulations of Sulodexide for the treatment of diabetic nephropathy in patients with both insulin dependent and non-insulin dependent diabetes mellitus. Oral...
|
|
|
7252828 |
Polysaccharide vaccine for staphylococcal infections
The invention relates to compositions of the capsular polysaccharide/adhesin (PS/A) of staphylococci . The PS/A may be isolated or synthesized and includes various modifications to the structure...
|
|
|
7214667 |
Drugs against articular failure
The object of the present invention is to provide a composition which exerts a higher effect on recovering health from articular disorders than that attained by amino sugars and glycosaminoglycans....
|
|
|
7214666 |
Composition of orally administered nutritional supplements to repair articular cartilage
Provided is a synergistic combination of nutritional supplements classified as Nutraceuticals and further combined with antioxidant vitamins and minerals that, when orally administered to mammals,...
|
|
|
7202230 |
Use of hyaluronic acid derivatives in the preparation of biomaterials with a physical haemostatic and plugging activity
The present invention describes the use of polysaccharide derivatives for the preparation of biocompatible and biodegradable biomaterials with absorbent properties for body fluids and physical...
|
|
|
7195675 |
Chitosan-containing polysaccharide, method for preparing the same and use thereof
The present invention herein provides a chitosan-containing polysaccharide and a method for the preparation thereof as well as a medicine and a food containing the polysaccharide. The...
|
|
|
7157431 |
Compositions of plant carbohydrates as dietary supplements
Compositions of plant carbohydrates for dietary supplements and nutritional support for promotion and maintenance of good health. Defined nutritionally effective amounts of one to eleven essential...
|
|
|
7153877 |
Method and composition for preventing or reducing the symptoms of insulin resistance syndrome
A method for preventing and or reducing the symptoms of insulin resistance and a related syndrome in persons comprises identifying persons having or at risk for having such symptoms, and...
|
|
|
7151099 |
Use of taurolidine and/or taurultam for treatment of abdominal cancer and/or for the prevention of metastases
Taurolidine and/or taurultam is administered during and after surgical removal of a cancerous tumor to treat abdominal cancer.
|
|
|
7141556 |
Process for the preparation of glucosamine salts
This invention relates to a process for the preparation of glucosamine sulfate, glucosamine hydroiodide, glucosamine pyruvate, glucosamine phosphate or their mixtures with glucosamine...
|
|
|
7138386 |
Preventives or remedies for arthritis
The present invention relates to pharmaceuticals, foods and drinks, food additives, animal feeds and feed additives comprising an N-acylated hydroxyproline derivative or a salt thereof, and an...
|
|
|
7138149 |
Dietary supplements and methods for treating pain and inflammation
The invention provides compositions such as dietary supplements. Such compositions can be used to reduce pain, inflammation, stiffness, and/or discomfort associated with inflammatory conditions...
|
|
|
7119110 |
Method and composition for preventing or reducing the symptoms of insulin resistance syndrome
A method for preventing and or reducing the symptoms of insulin resistance and a related syndrome in persons comprises identifying persons having or at risk for having such symptoms, and...
|
|
|
7119079 |
Bioadhesive pharmaceutical compositions
Disclosed are compounds having the formula
wherein R 2 is hydrogen, a monomeric glycoside or an oligomeric glycoside, R 3 is hydrogen, a monomeric glycoside, an oligomeric glycoside, or a...
|
|
|
7115588 |
Methods for treating a breach or puncture in a blood vessel
The present invention relates to compositions comprising semi-crystalline β-1-4-N-acetylglucosamine polymers (p-GlcNac) and methods utilizing such polymers modulation of vascular structure and/or...
|
|
|
7101859 |
Use of lipid conjugates in the treatment of diseases
The invention provides novel methods for treating disease based upon the medicinal use of lipids and phospholipids covalently bound to physiologically acceptable monomers or polymers....
|
|
|
7098195 |
Fluorinated glucosamine analogs useful for modulating post-translational glycosylations on cells
The present invention provides compositions and methods for inhibiting cell migration, e.g., lymphocytes and inflammation. The invention also provides an improved process for preparing fluorinated...
|
|
|
RE39245 |
Galactopyranosides and their use
The present invention relates to simplified synthesis, new carbohydrate-based products and practical use of different carbohydrate-based products. Examples of these are (Galα1-3Gal),...
|
|
|
7074775 |
Aminobutyramide conjugate and a pharmaceutical composition for treatment of neuronal disorders
A compound is provided that has the formula
NH 2 CH 2 CH 2 CH 2 C(O)N—R (I)
...
|
|
|
7074774 |
Use of N-acetyl-D-glucosamine in the manufacture of pharmaceutical useful for treating cardio-cerebrovascular anoxemia
The present invention has disclosed a use of N-acetyl-D-glucosamine in the manufacture of a medicament for resisting cardiac and cerebral ischemia and oxygen-deficiency. N-acetyl-D-glucosamine can...
|
|
|
7049300 |
C-glycoside compounds for stimulating the synthesis of glycosaminoglycans
C-glycoside compounds are suited for stimulating the synthesis of glycosaminoglycans containing a D-glucosamine and/or N-acetyl-D-glucosamine residue, advantageously hyaluronic acid, and/or...
|
|
|
7041657 |
Compositions and methods for modulation of vascular structure and/or function
The present invention relates to compositions comprising semi-crystalline β-1-4-N-acetylglucosamine polymers (p-GlcNac) and methods utilizing such polymers modulation of vascular structure and/or...
|